Established in 1986, Kent Pharma is one of the leading suppliers of generic and specialist medicines to the primary and secondary care sectors in the UK. Kent manufactures and distributes speciality off patent/ generic pharmaceuticals across the UK, Ireland and other international markets. The business is a UK market leader in several niche products, selling its products primarily through the hospital and pharmaceutical wholesaler channels. Kent's portfolio of products is diversified across multiple therapeutic areas with particular strength and depth in analgesic and anti-infectives, the latter of which are manufactured in Ireland by our sister company, Athlone Laboratories enabling us to provide a high-quality, reliable and robust supply of those products to our customers. Our portfolio contains many niche, value-added products which are complex to manufacture. With a strong pipeline of new product development and energised by our recent acquisition by Duke Street Capital in September 2019, Kent continues to grow and thrive as part of the Kent-Athlone Pharma Group.